|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Several studies, including histochemical ones, have indicated that nitric oxide (NO) of endothelial origin may be related to the pulmonary vasodilation that occurs at birth. Since no histologic studies have been done of the possible parallel perinatal increase in production of neuronal NO synthase (nNOS) by pulmonary nerve plexuses, we investigated the distribution of nNOS in fetal, neonatal, and adult mouse lung. Lungs from mice aged 13 d gestation to 6 d after birth and lungs of adults were studied through histochemistry for nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) activity and immunocytochemistry. Both techniques gave almost similar results in relation to time of appearance, distribution, and frequency of neural structures positive for NADPH-d and NOS. NADPH-d staining was also applied to whole mounts of developing and adult tracheae. Staining was found from gestational days 13 to 15 onward in a small portion of the neuronal population. In all stages studied, NADPH-d/NOS staining was found in neuron cell bodies in the hilar region and bronchiolar wall, as well as in neuronal processes. Labeled terminal nerve fibers with varicosities were more frequent in pulmonary blood vessels than in airways. In tracheae, similar NADPH-d/NOS-positive nerve plexuses were found. The presence of nNOS in fetal and neonatal mouse respiratory tract suggests that neurally derived NO must play a role in developing lung physiology. However, because no perinatal increase in the number or intensity of staining of nNOS-positive nerve structures was seen, no apparent relation between neural NO and vasodilation can be established at birth.
| |
Introduction |
|---|
|
|
|---|
The conversion of L-arginine to L-citrulline is catalyzed by the enzyme nitric oxide synthase (NOS) and results in the release of nitric oxide (NO). This simple molecule is known to be involved in diverse intercellular communications, such as those leading to relaxation of smooth muscle, regulation of blood pressure, inhibition of blood clotting, and cytotoxic activity by activated macrophages (1). NO has also been reported to act as a neuronal messenger (2). NO not only plays a regulatory role in the central nervous system, but also in the peripheral nervous system: neurons and nerve fibers immunoreactive for NOS have been reported in several mammalian organs (6). Two major classes of NOS enzymes produce NO: the constitutive isoforms present in neurons (type I) and endothelial cells (type III), and the inducible isoform (type II) found in macrophages and other cells (1, 12).
In the respiratory tract, NO is believed to play a role in various pulmonary physiologic processes, such as vasodilation and bronchodilation (13). In addition to studies showing the presence of NO of endothelial origin (14, 16), several physiologic studies have indicated the involvement of NO in inhibitory nonadrenergic, noncholinergic (iNANC) neurotransmission in pulmonary smooth-muscle relaxation (17). On the other hand, immunoreactivity for NOS has been shown in pulmonary neurons and/or nerves of some mammalian species (20). Furthermore, immunostaining for NOS has also been found recently in the respiratory nerve plexuses of lower vertebrates (26). The presence and significance of NO in the mammalian lung is a matter of current interest (e.g., inhaled NO is being used as a new therapy for different respiratory syndromes, taking advantage of the vasodilatory action of NO both in newborns [27, 28] and adults [29, 30]).
At birth, the transition from fetal to neonatal life involves relaxation of both vascular and airway smooth muscle (31). As a consequence of the decline in the resistance of pulmonary vessels and airways, an increase in blood flow and oxygenation takes place. Several chemical factors seem to be involved in respiratory control at birth (32). Recent physiologic studies indicate that endothelial NO is present at birth and may have an important role in the relaxation of vascular smooth muscle in the perinatal period and in postnatal maturation (33, 34). Moreover, increases in both the production of NO by endothelium (in lambs, [35]) and in the expression of types I and III NOS in late fetal and neonatal lung (in rats [36, 37]) have been found through biochemical and immunocytochemical methods.
It is unknown whether NO of neural origin could be involved in a similar manner, in the relaxation of airways and/or blood vessels at the time of birth, acting as an intercellular signal and/or neurotransmitter. In fact, no histochemical studies have been reported for the presence of NOS in mammalian respiratory tract neurons during late fetal life. The aim of the present study was to investigate the presence of neuronal NOS (nNOS) in mouse respiratory nerve plexuses, paying special attention to the occurrence of nNOS during lung development and in perinatal life, which has received little attention. Using both enzyme histochemical and immunocytochemical techniques, we investigated the time of appearance of nNOS in the developing mouse lung, as well as the distribution of nNOS-containing structures in fetal, neonatal, and adult lung.
| |
Materials and Methods |
|---|
|
|
|---|
Specimen Collection and Processing
A total of 52 Swiss mice were studied, consisting of eight sexually mature females (adult lungs, P-ad) and 44 mice at various stages of development, including gestational (E) days 13 to 19 and postnatal (P) days 0, 1, 2, and 6 (the age at which mouse lung is considered to be mature); four subjects of each age were studied.
The pregnant mice were anesthetized with 12.5% urethane (1 ml/100 g). The abdomen was opened and the fetuses were rapidly removed and chilled in ice. The newborn mice were anesthetized with ice. The chests of fetuses, newborn mice, and adults were opened and the tracheae and lungs were removed, except for fetuses on gestational days 13 and 14, which were immersed in toto in fixative.
Tissue for cryostat sections (lungs) and for whole mounts (tracheae) was fixed for 4 h at 4°C in 1% paraformaldehyde, and was then immersed overnight in 0.16 M phosphate-buffered saline containing 15% sucrose. Cryosections (6 to 8 µm thick) were collected on Vectabond-coated glass slides. For paraffin embedding, the material was immersed in Bouin's fixative for 20 to 24 h. Paraffin sections were 4 to 6 µm thick.
Conventional Staining
Paraffin sections were hydrated and stained with hematoxylin and eosin (H&E) or Masson's trichrome.
Histochemical Staining for Nicotinamide Adenine Dinucleotide Phosphate-Diaphorase
NOS-containing neurons were identified by the histochemical technique for nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d), which is usually regarded as a marker for nitrergic neurons. To study the morphologic relationship of NOS-containing nervous structures, the NADPH-d technique was applied not only to cryostat sections but also to whole mounts of specimen material. However, because the small size of fetal lungs did not allow an in toto study, the NADPH-d technique was applied only to tracheae.
Lung cryostat sections or whole mounts of tracheae were washed in phosphate buffer (PB) 0.1 M and then treated with 0.3% Triton X-100 in PB for 20 min at room temperature. After washing in PB, the specimens were incubated with a reaction mixture consisting of 1 mg/ml NADPH and 0.2 mg/ml nitroblue tetrazolium in PB at 37°C in the dark. Incubation for 45 to 60 min provided optimal staining. After washing in PB, tracheae were slit open on the ventral side and placed with mucosa side down on slides. Both cryostat sections and tracheae was covered with glycerol mounting medium followed by the application of coverslips.
Immunocytochemistry
Two polyclonal antibodies to nNOS, diluted 1:500, were used. Both antibodies were characterized by Western blotting (38, 39). One of the antibodies was raised against whole nNOS, purified from an extract of rat brain. The second antibody was raised against a synthetic peptide from the deduced sequence (LPLLQANGNDPELFQIPPELC) of cloned neural NOS (40). The specificity of this antibody in mouse lung was confirmed by its preabsorption with the synthetic peptide. In addition, a polyclonal antibody raised against protein gene product 9.5 (PGP9.5) and diluted 1:5,000 (a kind gift of J. Polak of the Department of Histochemistry of the Royal Postgraduate Medical School, London, UK) was used as a general neuroendocrine marker.
Paraffin sections were dewaxed with xylol. Cryostat
sections were pretreated with 0.3% Triton X-100 in Tris-HCl-buffered saline ([TBS] Tris buffer: 0.05 M, pH 7.36;
NaCl 0.5 M) for 45 min and dehydrated through graded alcohols. Both paraffin and cryostat sections were treated
with the avidin-biotin complex technique (41). Endogenous peroxidase was blocked by treatment with 3% H2O2
in methanol for 30 min. Sections were hydrated through
alcohols and then placed in TBS. Nonspecific binding sites
were blocked with 5% normal swine serum in TBS. After
overnight incubation at 4°C with the primary antibody,
sections were incubated for 30 min with biotinylated antirabbit immunoglobulins (E353; Dakopatts, Glostrup, Denmark), followed by a third incubation with avidin-biotin- peroxidase complexes (K355; Dakopatts) for 30 min. After
each incubation, sections were rinsed in TBS. The peroxidase
activity was demonstrated by means of 0.03% 3,3'-diaminobenzidine tetrahydrochloride (D-5637; Sigma, St. Louis,
MO) in sodium acetate/acetic acid 0.1 M, pH 5.6, containing 2.5% ammonium nickel sulfate, 0.2%
-D-glucose, 0.04%
ammonium chloride, and 0.001% glucose oxidase (42). The sections were counterstained with hematoxylin, dehydrated,
and mounted in DPX.
| |
Results |
|---|
|
|
|---|
Structure of Developing Mouse Lung
On gestational days 13 to 16 the developing mouse lung is composed of epithelial tubules made up by cuboidal or columnar cells, which are surrounded by mesenchymal tissue (Figure 1a). On the following days, the epithelium flattens, and on gestational day 18, in addition to the immature bronchioles just described, saclike primitive alveoli with an irregular outline (Figure 1b) are present. The primitive alveoli are subdivided into several alveoli through the gradual appearance of secondary crests, until the lung acquires the morphology of the adult animal, at about postnatal day 6. In mouse respiratory tract, once the extrapulmonary bronchi penetrate the lungs, the cartilage rings disappear and give rise directly to the bronchiolar tree, without intermediate intrapulmonary bronchi (Figure 1c).
|
Distribution of Nerve Plexuses in the Mouse Lung
In postnatal animals, nerve ganglia were easily identified by the presence of large neuron bodies with euchromatic nuclei and conspicuous nucleoli. In fetuses, the size of neuron bodies was smaller, obscuring their identification in conventionally stained ganglia. The distribution of mouse respiratory nervous structures was therefore studied by means of an antibody against the general neuroendocrine marker PGP9.5. With this, strong immunoreactivity was found in neural structures at all fetal stages studied (Figure 2). The nerve ganglia and nerves of both fetuses and adults were localized within or next to the walls of blood vessels, bronchi (Figures 2d and 2e), and bronchioles (Figure 2c), all three of which contained muscle cells. The size of the nerve ganglia decreased from the hilum to the bronchioles. The largest ganglia contained up to 35 neuron bodies per section, whereas the smallest ones contained only two or even one.
|
Distribution of NADPH-d-Labeled Nerve Elements in Mouse Lung
NADPH-d staining was first detected in neuron bodies of mouse pulmonary nerve plexuses from gestational day 13 (Figures 3a and 3b) onward, being present during lung development (Figures 3a to 3f) and in adulthood (Figures 3g and 3h). The NADPH-d-labeled cells observed at gestational day 13 were interpreted as neuron bodies on the basis of their labeling and localization, although they were smaller and showed fewer cytoplasmic processes (Figures 3a and 3b) than in later fetal stages (Figures 3c to 3f).
|
NADPH-d labeling was detected in both neuron cell bodies (Figure 3) and terminal nerve fibers (Figure 4) of mouse pulmonary nerve plexuses. Stained neuron bodies were found in the hilar region, next to blood vessels (Figures 3a and 3b) and bronchi (Figures 3d and 3e), as well as in the nerve ganglia located next to bronchioles (Figures 3c and 3f). Frequently, only one (Figures 3e and 3h) or a few (Figure 3g) positive neuron bodies were observed per nerve ganglion. Neuronal processes arising from the neuron bodies were neatly labeled with the NAPDH-d technique (Figures 3e to 3h). NADPH-d-positive neuron bodies, apparently in contact with one another through long neuronal processes, were also observed, especially in thicker cryostat sections (Figure 3c).
|
Thin terminal NADPH-d-positive nerve fibers showing varicosities were observed among the muscle cells of bronchi (Figures 4a and 4b), bronchioles (Figures 4c to 4e), and vessels (Figures 4f and 4g). They were more frequent in vascular (Figure 4g) than in bronchial (Figures 4a and 4b) or bronchiolar (Figures 4c and 4e) walls.
Distribution of nNOS-Immunoreactive Neurons in Mouse Lung
Immunoreactivity for NOS was first detected on gestational day 15 (Figure 5a), and extended through development (Figures 5a to 5f) and adulthood (Figures 5g and 5h). By comparison with NADPH-d staining, labeled neural structures showed no apparent differences in terms of location or frequency of NOS in fetuses, newborns, or adults. NOS-immunoreactive neuron bodies were also observed in the hilar region (Figures 5b to 5d) and next to intrapulmonary bronchioles (Figures 5a and 5e to 5h). Also, with the specific anti-nNOS antibody, only a small proportion of neuron bodies were labeled: most of the histologic sections of nerve ganglia did not contain stained neurons, and in labeled ganglia, only one or a few positive neurons were observed (Figure 5d). The two anti-nNOS antibodies used in the study produced the same immunostaining. Preabsorption with the corresponding antigen abolished immunostaining (Figures 5h and 5i).
|
Both the NADPH-d technique and immunocytochemistry for nNOS produced staining of the same neuron cell bodies, as shown in the cryostatic serial sections in Figure 6. Nevertheless, some differences between NADPH-d staining and NOS immunocytochemistry were observed. First, as indicated, immunoreactivity to NOS was detected later (gestational day 15, Figure 5a) than was NADPH-d staining (gestational day 13, Figures 3a and 3b). Second, although NADPH-d-labeled processes arising from neuron cell bodies were conspicuous (Figures 3e, 3f to 3h, and 6a), NOS-immunoreactive neuronal processes were more infrequent and shorter (Figures 5e and 6b) or even absent (Figures 5c and 5g). Additionally, terminal nerve fibers were detected only with the NADPH-d technique (Figure 4).
|
NADPH-d Activity in the Mouse Tracheal Plexus
As indicated, the tracheal tubular structure allowed application of the histochemical technique in whole-mount preparations of both fetuses (Figures 7a to 7e) and adults (Figure 7f). NADPH-d-reactive neuron cell bodies and nerve fibers were found in tracheae from gestational day 15 (Figure 7a) onward. Mouse tracheae in earlier stages than gestational day 15 could not be examined because they were too small to be removed without damage. The NADPH-d-positive nerve plexuses were similar in fetal and adult tracheae. As in the lung, only a small proportion of neuron cell bodies showed NADPH-d activity (Figures 7e and 7f). Tracheal neurons also showed conspicuous processes that seemed to establish an anatomic link between them, forming a fine network (Figure 7c). Nerve processes showed conspicuous varicosities (Figures 7a and 7e).
|
| |
Discussion |
|---|
|
|
|---|
The present histologic study identified NOS in the nerve plexuses of mouse lung and trachea from fetal life onward. The finding of both staining for NADPH-d and NOS immunoreactivity supports the presence of NOS in murine respiratory nerve plexuses. Labeling appeared during fetal development, at about gestational days 13-15, and remained throughout the postnatal and adult periods.
Studies of the functional significance of neurally derived NO in the mammalian respiratory tract have been done on postnatal specimens. We will therefore first discuss the functional significance of nNOS in the adult mouse respiratory tract, according to our findings.
iNANC Relaxation
The detection of NOS in neurons of murine and other mammalian lungs supports the hypothesis that NO is involved in iNANC-mediated relaxation of the respiratory tract. Nevertheless, the significance of NO involment in iNANC-mediated respiratory relaxation seems to differ among species and in different regions of the respiratory tract. It has been suggested that NO is the primary mediator of iNANC- mediated relaxation in some species (17, 19). Some authors have also stated that in humans, NO completely mediates iNANC-induced relaxation (13, 43), whereas others, using NOS inhibitors, have on the contrary shown that NO-mediated inhibition of iNANC-induced relaxation occurs to an extent of less than 50%, implying other mediators in the relaxation response (18). In agreement with the latter results is the finding that in human lung, only a small proportion of intrinsic neurons are immunoreactive for NOS (21). Similarly, only a few neurons in mouse respiratory plexuses are positive for NADPH-d or NOS, which also suggests a major involvement of other neurotransmitters in iNANC-mediated respiratory relaxation in this species.
NOS-immunoreactive neurons of both developing and adult mouse lung are localized in the hilar region and in the walls of bronchi and bronchioles. Previous studies of other mammals have also described NOS-positive neurons in the hilar region and in extra and intrapulmonary bronchi (21, 24), but not in bronchioles. These findings are in concordance with the existence in such mammals of nerve ganglia accompanying the large vessels and intrapulmonary bronchi, although only nerve fibers reach the bronchioles (44). The significance of NO in mammalian iNANC-mediated respiratory relaxation seems to be more important in trachea and bronchi than in peripheral airways (19). Such physiologic findings are in agreement both with the detection of NOS/NADPH-d-positive neurons and/or nerves in trachea and bronchi, and of only scarce NOS-positive nerve fibers in bronchioles (45), as well as with a reported decline in NOS-containing nerve fibers from upper to lower airways (22, 45). In the mouse lung, on the contrary, nerve ganglia, in addition to nerve fibers, accompany the bronchiolar tree. As shown in the present study, some NOS-positive neurons continue to be present in such small bronchiolar nerve ganglia. Both NADPH-d- labeled and NOS-labeled neurons and nerves are present in the bronchioles, which may indicate a more relevant role of NO in iNANC-mediated relaxation in mouse peripheral lung than in that of other species.
We observed thin, terminal NADPH-d-labeled nerve
fibers with varicosities near smooth-muscle cells
presumably their target cells
of airways and blood vessels in the
mouse. In other mammalian species, isolated nerve fibers
have also been observed near muscle cells (24, 25, 45). In
guinea pig lung (22) they have additionally been detected
in the alveolar respiratory region. In the mouse, we found
that the number of NADPH-d-positive nerve fibers in airways was smaller than in blood vessels at all stages studied.
This observation suggests that the involvement of NO in
iNANC-mediated relaxation of blood vessels may be greater
than in the airways.
Pending its ultrastructural confirmation, our findings in both cryostatic thick lung sections and in tracheal whole mounts seem to indicate a structural relationship between NOS-containing neurons. In the myenteric plexus, electron microscopy has reportedly shown contacts between NOS-positive and both NOS-positive and NOS-negative neurons, and the involvement of NO not only in iNANC-mediated relaxation but also in the regulation of neuronal activity has been suggested (8).
Fetal Lung
To our knowledge, the earliest description of immunoreactivity for nNOS in mammalian pulmonary nervous structures was made in nerve fibers of the newborn pig (25). Although no other fetal detection of nNOS in mammalian species can be compared with our findings, the early detection of NOS/NADPH-d labeling in mouse fetal lung is consistent with the biochemical extraction of nNOS from rat fetal lung (36). The early presence of NOS on gestational days 13-15 mouse lung suggests a putative involvement of neurally derived NO in fetal lung, although the role of NO during this period is yet unknown. The presence from fetal life onward of NOS-containing nervous structures similar to those of adult lung suggests that the iNANC system exists in the developing mouse lung. In fact, it has recently been shown that before birth the porcine tracheobronchial tree appears to be functionally innervated by nitrergic input to the smooth muscle (46). However, other possibilities cannot be discarded (e.g., the involvement of NO in the establishment and maturation of synaptic connections, which has been indicated for the central nervous system [47, 48]).
Because the number and localization of NOS-containing nervous structures in the mouse is similar in the developing and adult respiratory tract, the iNANC for respiratory control mechanism does not seem to be strengthened in the perinatal period in this species. On the contrary, a decrease in NOS-containing nerve fibers with age has been reported in postnatal pig lung, suggesting that neurally derived NO may be important in pulmonary adaptation to extrauterine life (25). In fact, it has been shown in porcine bronchi that after birth there is a gradual transition away from NO toward a catecholaminergic pathway of relaxation (46). Similarly, an increase in NOS protein, with maximal levels in perinatal life, has been reported in the fetal rat (36). As indicated, the present study did not confirm similar changes in the expression of nNOS through variations in NOS-containing nervous structures in the late fetal period. However, it is difficult to reach definitive conclusions about a role for NO in early respiratory regulation because the number of neurons immunoreactive for nNOS in mouse respiratory nervous plexuses was small.
In summary, the results of the present study indicate
that NO of neural origin is present in mouse lung from approximately gestational days 13 to 15 onward. Therefore,
in addition to endothelial NO
the importance of which
has already been claimed
neurally derived NO may be
considered to play a role in fetal and neonatal lung physiology. Further biochemical and physiologic studies are
needed to identify the precise contribution of neurally derived NO in the developing mammalian lung.
| |
Footnotes |
|---|
Address correspondence to: Dr. Laura Guembe, Department of Cytology and Histology, University of Navarra, 31080 Pamplona, Spain. E-mail: lguembe{at}unav.es
(Received in original form January 28, 1998 and in revised form July 17, 1998).
Abbreviations: inhibitory nonadrenergic noncholinergic, iNANC; nicotinamide adenine dinucleotide phosphate-diaphorase, NADPH-d; nitric oxide, NO; nitric oxide synthase, NOS; neuronal nitric oxide synthase, nNOS; phosphate buffer, PB; protein gene product 9.5, PGP9.5; Tris-HCl-buffered saline, TBS.Acknowledgments: This study was supported by the Spanish Ministry of Education and Science (DGICYT project no. PB93-0711) and the University of Navarra (PIUNA). The authors thank Dr. V. Riveros-Moreno (Wellcome Research Laboratories, UK) for the antisera against nNOS and the synthetic peptide (p-53), and Prof. J. Polak (Hammersmith Hospital, London, UK) for the antiserum against PGP9.5. The authors thank I. Ordoqui and A. Urbiola for their technical assistance.
| |
References |
|---|
|
|
|---|
1. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43: 109-142 [Medline].
2. Bredt, D. S., P. M. Hwang, and S. H. Snyder. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 27: 768-770 .
3. Snyder, S. H., and D. S. Bredt. 1991. Nitric oxide as a neuronal messenger. Trends Pharmacol. Sci. 12: 125-128 [Medline].
4. Garthwaite, J.. 1991. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14: 60-67 [Medline].
5. Bredt, D. S., and S. H. Snyder. 1992. Nitric oxide: a novel neuronal messenger. Neuron 8: 8-11 .
6.
Ward, S. M.,
C. Xue,
C. W. Shuttleworth,
D. S. Bredt,
S. H. Snyder, and
K. M. Sanders.
1992.
NADPH diaphorase and nitric oxide synthase colocalization in enteric neurons of canine proximal colon.
Am. J. Physiol.
263:
G277-G284
7. Schmidt, H. H. H. W., G. D. Gagne, M. Nakane, J. S. Pollock, M. F. Miller, and F. Murad. 1992. Mapping of neural nitric oxide synthase in the rat suggests frequent colocalization with NADPH diaphorase but not with soluble guanylyl ciclase, and novel paraneural functions for nitrinergic signal transduction. J. Histochem. Cytochem. 40: 1439-1456 [Abstract].
8. Llewellyn-Smith, I. J., Z. M. Song, M. Costa, D. S. Bredt, and S. H. Snyder. 1992. Ultrastructural localization of nitric oxide synthase immunoreactivity in guinea-pig enteric neurons. Brain Res. 577: 337-342 [Medline].
9. Belai, A., H. H. H. W. Schmidt, C. H. V. Hoyle, C. J. S. Hassall, M. J. Saffrey, J. Moss, U. Förstermann, F. Murad, and G. Burstock. 1992. Colocalization of nitric oxide synthase and NADPH-diaphorase in the myenteric plexus of the rat gut. Neurosci. Lett. 143: 60-64 [Medline].
10. Liu, L., and L. Barajas. 1993. Nitric oxide synthase-immunoreactive neurons in the rat kidney. Neurosci. Lett. 161: 145-148 [Medline].
11. Grozdanovic, Z., B. Mayer, H. G. Baumgarten, and G. Bruning. 1994. Nitric oxide synthase-containing nerve fibres and neurons in the genital tract of the female mouse. Cell Tissue Res. 275: 355-360 [Medline].
12. Förstermann, U., H. Schmidt, J. S. Pollock, H. Sheng, J. A. Mitchell, T. D. Warner, M. Nakane, and F. Murad. 1991. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42: 1849-1857 [Medline].
13. Belvisi, M. G., C. D. Sretton, M. Yacoub, and P. J. Barnes. 1992. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur. J. Pharmacol. 210: 221-222 [Medline].
14.
Chang, J. K.,
P. Moore,
J. R. Fineman,
S. J. Soifer, and
M. A. Heymann.
1992.
K+ channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide.
J. Appl. Physiol.
73:
188-194
15. Dupuy, P. M., S. A. Shore, J. M. Drazen, C. Frostell, W. A. Hill, and W. M. Zapol. 1992. Bronchodilator action of inhaled nitric oxide in guinea pigs. J. Clin. Invest. 90: 421-428 .
16. Van Camp, J. R., C. Yian, and F. M. Lupinetti. 1994. Regulation of pulmonary vascular resistance by endogenous and exogenous nitric oxide. Ann. Thorac. Surg. 58: 1025-1030 [Abstract].
17.
Fisher, J. T.,
J. W. Anderson, and
M. A. Waldron.
1993.
Nonadrenergic
noncholinergic neurotransmitter of feline trachealis: VIP or nitric oxide.
J.
Appl. Physiol.
74:
31-39
18.
Bai, T. R., and
A. M. Bramley.
1993.
Effect of an inhibitor of nitric oxide
synthase on neural relaxation of human bronchi.
Am. J. Physiol.
264:
L425-L430
19.
Yu, M.,
Z. Wang,
N. E. Robinson, and
P. H. Leblanc.
1994.
Inhibitory nerve
distribution and mediation of NANC relaxation by nitric oxide in horse
airways.
J. Appl. Physiol.
76:
339-344
20. Dey, R. D., B. Mayer, and S. I. Said. 1993. Colocalization of vasoactive intestinal peptide and nitric oxide synthase in neurons of the ferret trachea. Neuroscience 54: 839-843 [Medline].
21. Díaz de Rada, O., A. C. Villaro, L. M. Montuenga, A. Martínez, D. R. Springall, and J. M. Polak. 1993. Nitric oxide synthase-immunoreactive neurons in human and porcine respiratory tract. Neurosci. Lett. 162: 121-124 [Medline].
22. Fischer, A., P. Mundel, B. Mayer, U. Preissler, B. Philippin, and W. Kummer. 1993. Nitric oxide synthase in guinea pig lower airway innervation. Neurosci. Lett. 149: 157-160 [Medline].
23. Kobzik, L., D. S. Bredt, C. J. Lowenstein, J. Drazen, B. Gaston, D. Sugarbaker, and J. S. Stamler. 1993. Nitric oxide synthase in human and rat lung. Immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9: 371-377 .
24. Buttery, L. D. K., D. R. Springall, A. E. Bishop, and J. M. Polak. 1994. The distribution of nitric oxide synthase isoforms in normal and diseased tissues. Biomed. Res. 15: 57-62 .
25. Buttery, L. D. K., D. R. Springall, F. A. M. Dacosta, H. Oliveira, A. A. Hislop, S. G. Waworth, and J. M. Polak. 1995. Early abundance of nerves containing NO synthase in the airways of newborn pigs and subsequent decrease with age. Neurosci. Lett. 201: 219-222 [Medline].
26. Bodegas, M. E., A. C. Villaro, L. M. Montuenga, S. Moncada, V. Riveros-Moreno, and P. Sesma. 1995. Neuronal nitric oxide synthase immunoreactivity in the respiratory tract of the frog, Rana temporaria. Histochem. J. 27: 812-818 [Medline].
27. Kinsella, J. P., S. R. Neish, D. D. Ivy, E. Shaffer, and S. H. Abman. 1993. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr. 123: 103-108 [Medline].
28. Zayek, M., D. Cleveland, and F. C. Morin. 1993. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J. Pediatr. 122: 743-750 [Medline].
29.
Rossaint, R.,
K. J. Falke,
F. Lopez,
K. Slama,
U. Pison, and
W. M. Zapol.
1993.
Inhaled nitric oxide for the adult respiratory distress syndrome.
N.
Engl. J. Med.
328:
399-405
30.
Young, J. D.,
W. J. Brampton,
J. D. Knighton, and
S. R. Finfer.
1994.
Inhaled nitric oxide in acute respiratory failure in adults.
Br. J. Anaesth.
73:
499-502
31. Langercrantz, H., J. Milerad, and D. Walker. 1991. Control of ventilation in the neonate. In The Lung: Scientific Foundations. R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, and E. R. Weibel, editors. Raven Press, New York. 1711-1722.
32. Hodson, W. A. 1991. The first breath. In The Lung: Scientific Foundations. R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, and E. R. Weibel, editors. Raven Press, New York. 1665-1675.
33.
Abman, S. H.,
B. A. Chatfield,
S. L. Hall, and
I. F. McMurtry.
1990.
Role of
endothelium-derived relaxing factor during transition of pulmonary circulation at birth.
Am. J. Physiol.
259:
H1921-H1927
34.
Wang, Y., and
F. Coceani.
1994.
EDRF in pulmonary resistance vessels
from fetal lamb: stimulation by oxygen and bradykinin.
Am. J. Physiol.
266:
H936-H943
35.
Shaul, P. W.,
M. A. Farrar, and
R. R. Magness.
1993.
Pulmonary endothelial
nitric oxide production is developmentally regulated in the fetus and newborn.
Am. J. Physiol.
265:
H1056-H1063
36.
North, A. J.,
R. A. Star,
T. S. Brannon,
K. Ujiie,
L. B. Wells,
C. J. Lowenstein,
S. H. Snyder, and
P. W. Shaul.
1994.
Nitric oxide synthase type I and
type III gene expression are developmentally regulated in rat lung.
Am. J. Physiol.
266:
L635-L641
37.
Xue, C.,
P. R. Reynolds, and
R. A. Johns.
1996.
Developmental expression
of NOS isoforms in fetal rat lung: implications for transitional circulation
and pulmonary angiogenesis.
Am. J. Physiol.
270:
L88-L100
38. Springall, D. R., V. Riveros-Moreno, L. Buttery, A. Suburo, A. E. Bishop, M. Merrett, S. Moncada, and J. M. Polak. 1992. Immunogold detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 98: 259-266 [Medline].
39. Riveros-Moreno, V., C. Beddell, and S. Moncada. 1993. Nitric oxide synthase: structural studies using anti-peptide antibodies. Eur. J. Biochem. 215: 804-808 .
40. Bredt, D. S., P. Hwang, C. Glatt, C. Lowenstein, R. Reed, and S. H. Snyder. 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P450 reductase. Nature 351: 714-718 [Medline].
41. Hsu, S. M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580 [Abstract].
42. Shu, S., G. Ju, and L. Fan. 1988. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85: 169-171 [Medline].
43. Belvisi, M. G., J. K. Ward, J. A. Mitchel, and P. J. Barnes. 1995. Nitric oxide as a neurotransmitter in human airways. Arch. Int. Pharmacodyn. Ther. 329: 97-110 [Medline].
44. Nagashi, C. 1972. Functional Anatomy and Histology of the Lung. University Park Press, Baltimore. 180-242.
45. Ward, J. K., P. J. Barnes, D. R. Springall, L. Abelli, S. Tadjkarimi, M. H. Yacoub, J. M. Polak, and M. G. Belvisi. 1995. Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves. Am. J. Respir. Cell Mol. Biol. 13: 175-184 [Abstract].
46. Connellan, D. R., and H. W. Mitchell. 1998. Transition of functional innervation in the developing porcine airway from nitrergic to catecholaminergic. Br. J. Pharmacol. 123: 712-718 [Medline].
47. Riche, D., A. S. Foutz, and M. Denavitsaubie. 1995. Developmental changes of NADPH-diaphorase neurons in the forebrain of neonatal and adult cat. Dev. Brain Res. 89: 139-145 [Medline].
48. Lizasoain, I., C. P. Weiner, R. B. Knowles, and S. Moncada. 1996. The ontogeny of cerebral and cerebellar nitric oxide synthase in the guinea pig and rat. Pediatr. Res. 39: 779-783 [Medline].
This article has been cited by other articles:
![]() |
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Vaughan, T. V. Brogan, M. E. Kerr, S. Deem, D. L. Luchtel, and E. R. Swenson Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungs Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L834 - L843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Turley, L. D. Nelin, M. R. Kaplowitz, Y. Zhang, and C. D. Fike Exhaled NO is reduced at an early stage of hypoxia-induced pulmonary hypertension in newborn piglets Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L489 - L500. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bowler and J. D. Crapo Oxidative Stress in Airways: Is There a Role for Extracellular Superoxide Dismutase? Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S38 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Khassawneh, I. A. Dreshaj, S. Liu, C.-H. Chang, M. A. Haxhiu, and R. J. Martin Endogenous nitric oxide modulates responses of tissue and airway resistance to vagal stimulation in piglets J Appl Physiol, August 1, 2002; 93(2): 450 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. STEUDEL, M. KIRMSE, J. WEIMANN, R. ULLRICH, J. HROMI, and W. M. ZAPOL Exhaled Nitric Oxide Production by Nitric Oxide Synthase-deficient Mice Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1262 - 1267. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |